Industry Discovery & Development Partnership (IDDP) Program
The IDDP Program funds industry-led research to develop innovative, commercially promising therapies and technologies for type 1 diabetes aligned with Breakthrough T1D’s scientific priorities.
Funder: Breakthrough T1D
Due Dates: Rolling (inquiries accepted year-round)
Funding Amounts: Typically up to $1,500,000 total over 3 years (larger budgets considered with strong justification; no indirect costs allowed)
Summary: Supports for-profit organizations conducting research aligned with Breakthrough T1D’s type 1 diabetes priorities to advance commercially promising therapies and technologies.
Key Information: Requires company matching funds; proposals must closely align with Breakthrough T1D research strategy.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D provides funding to for-profit organizations for research projects that are highly aligned with Breakthrough T1D’s strategic priorities in type 1 diabetes (T1D). The program leverages the commercial development expertise of industry with Breakthrough T1D’s research and advocacy leadership, aiming to accelerate the translation of innovative treatments, technologies, and therapies for T1D. Projects should have clear potential for commercial development and a strong scientific rationale relevant to the unmet needs in T1D.
Breakthrough T1D welcomes inquiries from interested companies throughout the year. Projects may be proposed in response to specific requests for applications (RFAs) or as unsolicited proposals, provided they fit the foundation’s research strategy.
